Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Podcast: AI in stroke - Using deep learning to predict clinical outcomes after stroke
jan 2024 | Neuro-vasculair